Oric Pharmaceuticals, Inc. (ORIC) stock

ORICNasdaqPharmaceutical PreparationsFiscal year ends December 31

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 3, 2026Score 7/30

$8.50−0.50 (-5.56%)

Close on Nov 12, 2026Market cap $881.05MP/E –Yield –

Oric Pharmaceuticals gross margin

Gross margin is gross profit as a percentage of revenue.

Oric Pharmaceuticals has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

See a number that looks wrong?